PTEN and cancer: This study found that a majority of solid tumors from a diverse range of cancer types display a potential aberrant activation of the mTOR pathway, and a minority of solid tumors contain functional mutations in the PIK3CA and PTEN genes (including for PTEN, a loss of expression also potentially related to epigenetic-silencing).